Mounjaro 5mg Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, a first-in-class dual-incretin therapy. This injection is primarily used to manage blood sugar levels in adults with type 2 diabetes mellitus who are unable to achieve adequate glycemic control through oral antidiabetic medications, diet, and exercise. By mimicking the action of two natural incretin hormones GLP-1 and GIP Mounjaro enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. These mechanisms help lower post-meal blood sugar levels and improve overall metabolic control. Administered once weekly via subcutaneous injection, it offers convenience and long-term benefits for diabetes management. While Mounjaro has shown potential for weight loss in clinical trials, it is not approved for weight loss or the treatment of obesity without a valid prescription and proper medical evaluation. Its off-label use for weight management should only be under the supervision of a healthcare professional. Caution is advised in individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disorders. Patients frequently ask what is the price of mounjaro in india as availability and cost may vary depending on the region, pharmacy, and supply. For accurate pricing and access, it is best to consult licensed medical suppliers or pharmacies that stock this medication.